© Foto: Unsplash
Realtime | Geld | Brief | Zeit |
---|---|---|---|
119,80 | 120,80 | 12.05. | |
120,40 | 121,00 | 10.05. |
© Foto: Unsplash
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mi | Coterra Ups Production Guidance despite Q1 Income Slump | ||
06.05. | Coterra Energy (CTRA) Q1 Earnings and Revenues Beat Estimates | ||
03.05. | Earnings call: Coterra Energy surpasses Q1 production expectations | ||
03.05. | Coterra Energy Inc. - 10-Q, Quarterly Report | ||
03.05. | US STOCKS TC Energy, Cloudflare, Coterra Energy |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | MSD's maternal health initiative passes big milestone | ||
Do | Merck's Keytruda plus chemo comes up short as post-surgery therapy in newly diagnosed endometrial cancer | ||
Do | Merck's Phase 3 Trial Of KEYTRUDA Plus Chemotherapy In Endometrial Cancer Fails To Meet Primary Goal | KENILWORTH (NJ) (dpa-AFX) - Drug major Merck & Co., Inc. (MRK) announced Thursday that the Phase 3 KEYNOTE-B21 trial evaluating its anti-PD-1 therapy KEYTRUDA (pembrolizumab), in combination... ► Artikel lesen | |
Do | Merck & Co verfehlt Studienziel bei Blockbuster-Krebsmedikament | ||
Do | Merck' Keytruda Receives Approval From Health Canada For Biliary Tract Carcinoma In Adults | KENILWORTH (NJ) (dpa-AFX) - Thursday, Merck & Co., Inc. (MRK) announced that Health Canada has approved Keytruda, also known as pembrolizumab, for the treatment of adult patients with locally... ► Artikel lesen |
Unternehmen / Aktien | Kurs | % |
---|---|---|
COTERRA ENERGY INC | 26,295 | +0,84 % |
MERCK & CO INC | 120,80 | 0,00 % |